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Background: In a study of prevention of mother-to-child transmission of HIV (PMTCT) by triple antiretroviral therapy (ART)
in Dar es Salaam, Tanzania (the Mitra Plus study), retrospective viral load testing revealed a high and increasing frequency
of detectable viral load during follow-up for two years postnatally in women given continuous ART for their own health
suggesting poor adherence. This study explored women’s own perceived barriers to adherence to ART post-delivery so as
to identify ways to facilitate better drug adherence among women in need of ART for their own health.
Methods: Semi-structured interviews were conducted with 23 of the 48 women who had detectable viral load at
24 months postnatally. Content analysis was used to analyze the data.
Results: Most women in the study did not acknowledge poor adherence until confronted with the viral load figures.
Then, however, they revealed multiple reasons for failing to adhere. They said that their motivation to take ART
decreased once they had protected their children from becoming infected and successfully weaned them. Feeling well
for some, and a feeling of hopelessness for others, also decreased motivation to continue ART. The overwhelming
demands of everyday life, poverty and lack of empowerment also posed significant barriers to long-term adherence.
The need to keep their HIV status a secret and not let anyone see them taking the drugs was another steep barrier.
Conclusion: Reasons for postnatal failure to adhere by mothers put on ART for life during pregnancy included lack of
motivation to continue ART after weaning the child, poverty and stigma. Projects that simultaneously address stigma,
poverty and women’s lack of empowerment may be necessary for PMTCT and ART to reach their full potential. Our
results indicate that the new WHO proposal to start all HIV-infected pregnant women on lifelong ART regardless of
CD4 cell count needs to address the challenging realities of women in resource-poor contexts if it is to be successful.
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Prevention of mother-to-child transmission (PMTCT) of
HIV is an entry point to lifelong antiretroviral therapy
(ART) among pregnant women found to be HIV-infected
[1]. Most of these pregnant women are asymptomatic be-
fore diagnosis. So far in low-income settings, life-long ART
has only been offered to pregnant women who have a low* Correspondence: mmosi_2@yahoo.com
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reproduction in any medium, provided the orCD4 cell count but this scenario is changing [2]. In
high-income countries, the use of prophylactic ART
combined with elective caesarean section and avoidance
of breastfeeding has almost eliminated mother-to-child
transmission (MTCT) of HIV but this is not the case in
resource-poor settings [1]. Earlier studies in low-income
countries have shown that PMTCT, involving ART during
the late stages of pregnancy and postnatally, combined with
exclusive breastfeeding for six months, can reduce MTCT
to between 1% and 5% at 6 months after delivery [3-7].
Maintaining adherence to ART over time is a challenge
in many settings also in sub-Saharan Africa where thel Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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2009 was 70% [8]. A large body of research has identified
social, cultural and economic barriers to antenatal and
postnatal adherence to ART over time [9-13]. Low levels of
adherence are problematic both because poor adherence to
ART leads to virologic failure, increased risk of MTCT and
a high risk of drug resistance that may require a change to
more expensive treatment regimens [14-17].
Mitra Plus was an open-label, non randomized,
prospective PMTCT study including 501 pregnant
HIV-1-infected women in Dar es Salaam, Tanzania,
initiated on triple antiretroviral (ARV) drugs from
34 weeks of pregnancy until 6 months post delivery
(the breastfeeding period) that assessed MTCT and infant
mortality rates. Women enrolled with CD4 cells < 200/μl
were put on ART for life [4] and received significant
adherence counseling and support in addition to trans-
port incentives, free medical services including man-
agement of opportunistic infections, as well as formula
or food supplements for their children after stopping
breastfeeding if needed.
After the end of the Mitra Plus study (2009), viral load
testing showed that, contrary to women’s self-reported
adherence, a high proportion of the women who were to
be on ART for life had detectable viral loads at 12 months
and 24 months post-delivery.
We therefore decided to conduct semi-structured
open-ended interviews to explore women’s own perceived
barriers to adherence to ART post-delivery and after the
cessation of breastfeeding so as to identify ways to facilitate
better drug adherence among women in need of ART for
their own health. This knowledge is important to enable
successful scale-up of the most recent WHO guidelines for
PMTCT [18] including the new proposal to start lifelong




This was a qualitative study using inductive content
analysis. It was thought to be the best method which
could elicit extensive discussions that could reveal
women’s perceived reasons for poor drug adherence.
Qualitative interview methods facilitate rapport while
enabling the interviewer to maintain focus on the issue
at hand [19,20].
Setting
The Mitra Plus clinic is located within the Muhimbili
National Hospital compound, Dar es Salaam, Tanzania.
It is a small clinic with no sign on the door in order to
reduce the risk of stigmatization of visitors. Women were
provided with bus fare to and from the clinic. Treatment
of any medical condition they had during the study periodwas also provided free of charge. Those who could not
afford formula or food supplements for their children after
stopping breastfeeding were supplied with food in form of
flour, milk powder and nutritional supplements.
Participants and sampling frame
We interviewed 23 HIV-infected women enrolled in
the Mitra Plus PMTCT study with a CD4 cell count
of < 200/μL who were put on ART for life and followed for
2 years postpartum. Women who had detectable viral load
of >400 copies/mL at the end of 2 years follow-up were
purposefully selected. The interviews were conducted
between August 3rd and 24th, 2009 but the actual tracing
and making of appointments was done 2 months prior to
interviews as most of the women had completed their
follow up period and had been discharged to HIV care and
treatment centers.
Of the 501 pregnant women enrolled in the Mitra Plus
study, 86 had CD4 cell counts below 200/μL at enrollment
and out of these 56 women were available for follow-up for
at least 2 years post-delivery. Forty-eight out of these 56
women (85.7%) had detectable viral load at the end of
24 months. All 48 were traced and invited for interviews
(as they had been discharged from the project and had
joined care and treatment centers for HIV); of these, 23
viremic women agreed to be interviewed and tape-recorded
by signing an informed consent form. Ten women did
not want to be tape-recorded and were excluded from
the study as the authors had agreed to deal only with
tape recorded interviews for uniformity and completeness,
8 were not able to be traced; and 7 gave no reason for
declining participation.
Data collection
A semi-structured interview guide composed of open-
ended questions was pretested on 2 women in this study
who were eligible but refused to be tape recorded. The
guide was amended and was then used during the inter-
views. An in depth face to face interview at a place of
choice selected by each woman was thought to be the
best method for enabling women who undoubtedly felt
stigmatized because of their HIV infection to express
themselves freely and explain the challenges they faced
[21]. The first author (MN) and one research assistant
conducted the interviews. Both are females, fluent in
Kiswahili and English and competent in qualitative
interview. The interviews were conducted in Kiswahili
by politely asking and probing the participants about
their lives and their experiences of taking ART. We
tried to discern whether or not they had been adherent,
and if not, why not. The interviews were tape-recorded
and lasted between 45–60 minutes.
During the interviews we also used follow-up case
notes of the client from enrolment to date, drug dispensing
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to help the client remember events that had occurred
during and after the breastfeeding period. One to two
interviews were conducted daily and field notes and a
field diary were kept. Peer debriefing sessions were done
after the interviews to check if any issues had risen from
the discussions and to help plan for the next activity. This
also helped detect when saturation had been reached.
Data management and analysis
Data analysis began during data collection and continued
to evolve throughout the research as guided by Kvale [19].
This was important as it helped to plan and shape the next
interview (emergent design). Tape-recorded interviews were
transcribed verbatim by the research assistant and the main
researcher and thereafter, the Swahili transcripts were
translated to English by the research assistant and checked
by the first author. The first author went through the
transcripts again and compared them with the audiotapes
to make sure no part of the interview was missed.
Data was analyzed using content analysis. According
to Graneheim and Lundman [22] content analysis focuses
on selecting the unit of analysis, meaning unit, codes,
categories and theme(s). The first and second author,
an anthropologist, independently coded the transcribed
data. Table 1 provides an example of meaning units,
condensed meaning units and codes. They compared
the two coding for consistency and consensus on data
interpretation. The codes were reviewed and tested by
RP and AME to verify the categories.
Trustworthiness of the study
Trustworthiness is the ability of the study methods to
capture the reality of those being studied. We deem the
results of this study to be trustworthy for several reasons:
women’s accounts were largely in agreement with each
other even though the women did not know much of one
another; data saturation was reached before all the inter-
views were carried out; although the women’s accounts go
beyond results of previous studies they do not contradict
any previous research and are in line with what we know
about life in poverty. Furthermore the first author MN
had worked as a clinician and researcher in the study sinceTable 1 Example of a meaning unit, a condensed meaning un
Meaning unit
I took drugs properly when I was pregnant and during breastfeeding.
After that and as of today I have a lot of responsibilities that I have to
wake up at 4 am and I easily forget the morning dose. But it happened
when the child was around one year that I stopped taking drugs…..not
a single pill for almost 6 months. I even stopped coming to the clinic. I
felt that I was cured. I had gained significant weight and thought I was
now ok. I also traveled to Bagamoyo and Tanga for business purposes.
Then I had to bring the child to the clinic. They asked me why I had
disappeared and was not taking drugs. I had no good reason.recruitment, participating in antenatal follow-up, delivery
of some of the women and postnatal follow-up making
her well acquainted with the women, and they with her.
The interviews were also conducted in one of the women’s
native language, Kiswahili. The trustworthiness of the data
analysis was further ensured by the use of follow-up case
notes, peer debriefing sessions and joint analysis of the
data by a research team composed of multiple professions
(physicians, experts in public health, anthropologist).
Ethical considerations
The main study protocol was approved by the institutional
review boards (IRBs) of Tanzania, National Institute for
Medical Research and Muhimbili University college of
Health and Allied Sciences. Women were interviewed only
when they had understood the purpose of the study, signed
a written consent form and were ready to be tape-recorded.
Consent for making phone calls or actively tracing them at
their residency was signed during enrolment.
Results
Participants
The majority of the participants (17/23) had primary
school education and 20 of the 23 interviewed women
ran small-scale businesses generating low incomes. Only
three had salaried jobs – nurse, secretary, and police
officer. The women were between 25 and 45 years old,
and the majority (17/23) had more than one child. Eight
women were married, seven were cohabiting, five were
widows, two were divorced and one was single. Fifteen
women had disclosed their HIV sero-status to at least
one member of the family, but not necessarily to their
partner (Table 2).
Most of the interviewed women ultimately, although not
initially, acknowledged that they had been non-adherent to
ART at some point during the study period. They only
conceded that they had missed taking pills well into the
interviews when informed about their high viral loads.
Main findings
The main reasons why women neglected to adhere to
ART postnatally were grouped in 6 categories: (1) they
lacked motivation after having succeeded in preventingit and codes
Condensed meaning unit Codes
Pregnancy and breastfeeding motivation
to adherence.
Ensure baby was safe.
Responsibilities make it easy to forget and
even stop taking drugs.
Busy
Forget to take drugs
Stopped coming to the clinic as I felt cured Feeling well
Table 2 Participants characteristics
Id number Age Marital status Parity Disclosure Profession Education Partner’s HIV status
1 35 married 4 no house-wife class 7 not known
2 38 married 1 no nurse College not known
3 37 married 2 yes tailor form 4 positive
4 40 widow 3 yes police form 4 positive
5 33 widow 3 yes sells food class 7 positive
6 28 divorced 1 yes saloon attendant class 7 negative
7 38 cohabiting 2 yes house-wife class 7 negative
8 28 cohabiting 1 yes hotel attendant class 7 negative
9 38 single 1 no sells food class 7 not known
10 36 married 3 yes sells fruits class 7 not known
11 45 married 4 yes sells food class 7 not known
12 37 widow 2 no gardener class 7 not known
13 33 divorced 3 yes sells food class 7 not known
14 29 married 3 no sells fruits form 4 not known
15 36 widow 4 no sells food class 7 positive
16 34 married 1 yes personal secretary form 4 negative
17 32 widow 3 no sell magazines class 7 not known
18 32 cohabiting 3 no sells food class 7 not known
19 34 cohabiting 1 yes house-wife class 7 not known
20 36 cohabiting 2 yes gardener class 7 positive
21 33 married 4 yes sells food no formal education not known
22 36 cohabiting 3 yes business woman class 7 not known
23 32 cohabiting 3 yes watchman class 7 positive
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ill; (3) life felt hopeless; (4) living in poverty constrained
their ability to adhere; (5) the demands of everyday life
were overwhelming; (6) they had to hide their ART due
to the stigma of being HIV-infected making it difficult
to follow the drug regimen.
Lack of motivation after saving the child
Eleven of the 23 women indicated that their motivation
to take ART was high while they were still breastfeeding
and protecting their children from infection despite side-
effects and stigma related difficulties. Once they weaned
their children and knew the baby was well, women’s incen-
tives to adhere to ART declined dramatically; despite low
CD4 cell counts. As one woman described her situation:
“I used to sleep all the time, as I was very weak. It was
the same when I was breastfeeding. But I was afraid to
stop taking them (the ARVs), as I didn’t want to
transmit the virus to my baby. So when I stopped
breastfeeding I was now sure that I cannot infect my
child and I could now have drug holidays. I could stay
for 3–4 days without taking the drugs.
(34 years, cohabiting, primary education)For some women it was the feeling of despair that led
them to stop taking their drugs after breastfeeding.
“Yes, I always remembered [to take drugs] but there
are days when I was in some dilemma so did not feel
like taking them so I did not take them. The baby had
already stopped breastfeeding. I can say that I had lost
hope. At that time my husband had died, there were
family wrangles. It got to a time where I would miss
my drugs for even a week. Not that I forgot to take
them, I just did not want to take them. I thought it
was okay if I died. Yes, I did but I gave myself hope
because of my child. My child gave me strength in that
I felt I had to help him. After I stopped breastfeeding
that is when I lost hope completely.” (Client started
crying bitterly)(40 years, widow, secondary education)
Feeling well
Seven women stated that they felt relatively well and
therefore did not think that stopping treatment would
be harmful.
“After [pregnancy and breastfeeding] and as of today I
have a lot of responsibilities; I have to wake up at
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happened when the child was around one year that I
stopped taking drugs-- not a single pill for almost
6 months. I even stopped coming to the clinic. I felt
that I was cured. I had gained significant weight and
thought I was now okay. I also traveled to Bagamoyo
and Tanga for business purposes. Then I had to bring
the child to the clinic. They asked me why I had
disappeared and was not taking drugs. I had no good
reason.” (32 years, cohabiting, primary education)
Another woman who also felt it was difficult to take
the drugs when she was not feeling sick noted that it
was extra difficult to adhere when her children asked
“Why do you take drugs every day, what are you suffering
from?” (40 years, widow, secondary education). This
reluctance to take the drugs even when feeling well was,
predictably, more common among the women who had
not disclosed their status and who were poorer and
therefore dependent on their families for survival.
Feeling of hopelessness
As most of the women were diagnosed to be HIV infected
when they were screened at the antenatal clinic they had
no time to prepare themselves psychologically and adapt to
a new way of life including ART adherence despite the
counseling they got. Four women spoke on how they
lost hope in life and were less interested in taking ART
especially after saving the child as one of them said;
“There were times when I wondered of what benefit I
was to be alive. My husband died and he left me
pregnant and maybe I could have been happy taking
care of the child but the baby also died. I remained
alive just to take this medicine how can that
be?”(37 years, widow, primary education,)
Poverty and the constraints it has on adherence
Fifteen of the 23 interviewed women explained how
difficult it was for them to incorporate all of the demands
of PMTCT including adherence to ART for life into lives
already burdened by poverty and the struggle to survive.
Most of the women in this study had only primary school
education and low income if any. Some, for example, had
small stands from which they sold food, earning them
enough income for one or two meals a day. Only three
women had formal employment. The other twenty were
dependent on their small businesses, husbands or partners
to complement their meager irregular incomes for food,
formula, shelter, clothing and other basic needs in life. As
one woman said;
“I was pregnant, sick, diagnosed to be HIV infected,
partner runs away from me and had no source ofincome. The care and service that I got from this clinic
was the one that kept me alive…” (32 years, cohabiting,
primary education)
Not having money for food was a common reason for
women to miss taking their drugs both because the
ARVs make them feel more hungry, experience more
side effects and also because they had been informed to
take the drugs with food. As this woman complained;
“They tell us that we should eat fruits and vegetables
and here in Dar es Salaam one has to buy all these
things. They should maybe give us some assistance on
this. At the moment a day may even pass without a
meal and one is not even able to afford an orange.”
(37 years, widow, primary education).
The women explained how important it was for them to
have enough food to eat so that they could take their drugs;
otherwise the drugs made them weak and they would hesi-
tate to take the next dose if they had an empty stomach.
“If for example one decides to take the ARVs before
eating it becomes difficult to even walk. One feels
dizzy but if one has eaten well then takes the drugs
then you don’t feel the effects at all.” (38 years,
cohabiting, primary education)
The overriding impression was that the women were
disempowered vis-a-vis both their relatives and male
partners. Many were entirely dependent on their partner
for financial support and with minimal negotiation power.
Disclosure of HIV status to their partners or relatives, that
potentially could have supported the women to take ART
was associated with a strong, and apparently realistic, fear
of abandonment and only a minority had disclosed to their
families, leaving them very much alone in their struggles to
be good mothers while also taking care of their own health
and daily survival struggles, being provided drugs but no
food to take the pills with.
The unceasing demands of daily life
Ten women described how in the long run and mostly
after they had stopped breastfeeding they got seriously
involved in their normal duties and could easily forget to
take their drugs or could not find time to go to the clinic
for drug refills as follows;
“There are days I forget to carry my drugs with me
and I have to wait till evening to take them. No, I am
not less keen [after I stopped breastfeeding] but maybe
I am just too overwhelmed with work such that I may
remember about the drugs at 10 am and I will be an
hour late. (38 years, cohabiting, primary education)”
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employed. I used to hide and go to get the drugs but
when I got here they had either closed or the queue
was too long and I could not wait because I had the
keys for my employers’ house. Sometimes I would ask
the nurse to serve me first but the other clients would
complain.” (28 years, cohabiting, primary education)
A few women said that they had many little things in
their lives that all together would make them too tired
to take drugs.
“Sincerely speaking I cannot really pick on one thing
that was disturbing me. I just had the normal
hardships of life but I cannot pick on one specific thing
that bothered me. Maybe taking care of my
handicapped child could have taken a toll on me. I
have been hospitalized four times with her, the first
time she was operated for cleft lip and palate.”
(33 years, divorced, primary education)
Another woman said;
“But I’m a human being. Do you think I like
forgetting to take my drugs? Really sometimes a day
or two would pass without taking drugs.”
(36 years, cohabiting, primary education.)
Some women explained that they had to travel frequently
and cited this as the reason for poor drug adherence. So
most of the women were very mobile and this tended to
interfere with proper drug adherence since they sometimes
run out of the drugs, forget to take them on a trip, or got
motion sickness while travelling, which prevented them
from taking the pills as one woman says;
“There is a time when my mother was sick and I
travelled to my mother’s place. I stayed there for one
month and I ran out of the medicine.”(45 years,
married, primary education)
The effect of HIV related stigma on drug adherence
Ten women spoke explicitly about stigma. Because HIV
infection is still highly stigmatized in Tanzania, women are
reluctant to let others see any activity that could disclose
their HIV status, including taking medication, breastfeeding
exclusively (as people are used to mixed feeding), or going
to the clinic to get drugs. As one woman described being
HIV positive said,
“This is a secret disease. You should not go around
spreading news that you are infected because once
people get to know that you are infected they
discriminate you. People try to avoid you and wouldprefer to stay far from you.” (33 years, married, no
formal education).
The stigma of HIV arises in part because people in the
society associate HIV infection with promiscuity and
hence considers it shameful, sinful, and even a punishment
from God.
“By the time I got tested, people thought that if one
was HIV positive then they were prostitutes…..then I
would have felt ashamed and embarrassed [to disclose
my status]”(35 years, married, primary education)
Since most of the people in Dar es Salaam are poor
and tend to live in very close contact with their extended
family and with neighbors, keeping a positive HIV status
secret is very difficult. Most women with small children
are dependent on others for support and childcare, so
having to take drugs secretly at definite times and having to
exclusively breastfeed sometimes posed an insurmountable
challenge. Many women related how they made consider-
able efforts to hide that they were on ART.
“I tried my level best not to forget taking my drugs. At
times the house would be full of guests but I would just
find a way to escape with water from the sitting room
into the bedroom where I could take my medicine in
private. I always made sure that not more than an
hour passed past the time I was supposed I take my
next dose. Most of the time while at the village I
wouldn’t take drugs at the appropriate time due to the
presence of people. This would sometime force me to
swallow them without water and drink water
afterwards.” (33 years, married, no formal education)
Women felt forced to constantly come up with new
lies in order to conceal their practices of PMTCT and
adherence to ART while still accepting the support they
needed from other family members as one woman said;
“I told [my mother] that I wanted to stop breastfeeding
at six months because my work involved me being
around fire and that would make my breast milk too
hot. If I then breastfed the baby, it would make the
baby have diarrhoea. I told her that the doctor had
told us that those women who do my kind of work
should not breastfeed because it will cause problems
for the baby. My mother understood that and agreed
with me.” (33 years, divorced, primary education)
Clearly, adherence to the ART regimen and exclusive
breastfeeding posed grave problems for most of these
women who had to hide their HIV status to keep their
position in society, to get respect from family and
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from boyfriends or husbands.
Discussion
The majority of the HIV-infected women in this study
who started ART for life during pregnancy because of low
CD4 cell count had developed detectable viral load at
24 months after delivery. This finding was particularly
surprising given that most of the women reported
adherence and were clinically doing well. Most of the
women acknowledged poor adherence and gave explana-
tions for it after being informed about their viral load trend.
Previous studies have found that costs of transport to
and from the clinic, health clinic fees, and lost wages
due to long waiting times at clinics have been the main
barriers to adequate ART adherence [11,13,23-25]. Our
findings suggest, however, that despite provision of free
ART drugs in an ideal setting with continuity among
providers as well as “extras” like bus fare, free medical
services, and management of opportunistic infections, it
was still a challenge for the women to adhere adequately
over a two-year period. We discovered that the motivation
to adhere to ART dropped after cessation of breastfeeding
and saving the child. The drop in motivation was
compounded by poverty, the overwhelming demands
of everyday life, and the fear of stigma if relatives and
neighbors found out they were infected with HIV.
Motivation was also affected by the fact that most women
felt well and were clinically stable and had been put on
ART because they were diagnosed during pregnancy.
However, all the women had been informed that their
CD4 cell counts were low and that they needed to adhere
to ART for life. To our knowledge this is the first study to
document a decrease of motivation to adhere to lifelong
ART after cessation of breastfeeding.
Some of the other reasons we found for non-adherence
have also been reported in previous studies: the stigma of
HIV [24,26], the forced secrecy around the disease and
around taking ART, general poverty, the overwhelming
demands of everyday life, a general sense of hopelessness,
and a sense that one is well and therefore need not follow
the demanding drug regimen [11,13,15,27-30]. The
gripping detail in which women described their travails,
however, breathes life into the challenges to adhering to
ART even among those women who need the medication
for their own immediate health and survival, many of
whom were single caretakers of their infants.
Most women in this study had consistently reported
high ART adherence during the follow-up in the Mitra
Plus study and some even kept insisting, until we
showed them the viral load results. Social desirability
may be particularly strong among mothers given the
strong expectations they face from health care staff in
terms of ART adherence and our study suggests thatself-report is not a reliable measure as it may well exag-
gerate adherence rates. This is very important clinically
as poor adherence and virologic failure have serious
consequences including increased risk of morbidity and
mortality and development of drug resistance which can
be costly to manage in resource-limited settings [14-16].
Poverty and HIV-related stigma combined with cul-
tural gender norms and traditions, significantly reduces
women’s power to make decisions regarding their own
health in this Tanzanian society, and is probably quite
generalizable to many other urban sub-Saharan African
settings. Women are generally less educated and often
lack their own income making them dependent on men
for survival [31,32]. Lack of food and crowded housing
conditions are real barriers to ART adherence directly
linked to poverty. Public awareness of PMTCT and the
relationship to breastfeeding and early weaning makes
both adherence to ART and exclusive breastfeeding a
major challenge especially among the most vulnerable,
least empowered women due to societal stigma associated
with HIV causing neighbors and relatives to closely observe
and gossip around any signs of HIV-related deviations
from normal post-partum behavior. This challenge may be
dealt with by introducing structural interventions aimed at
alleviation of poverty, food-shortages and the hardships of
women’s lives such as educational opportunities, small
scale business or job-training support, more involvement
of fathers and partners in pregnancy and child-care at the
community level. Efforts should also be made to reduce
stigma and improve compliance by protecting and promot-
ing the client’s right to privacy and confidentiality both in
the community and in healthcare settings.
Methodological considerations
The major limitation of this study is that it was done at
the end of the follow up period when women might have
forgotten what really happened in the past 2 years. Case
notes kept in the clinic were used to try to remind them
of some events that happened as they were recorded at
certain time points during their follow up period. The
fact that MN worked in the project throughout the study
period and was well known by the participants before
the interviews could have caused some social desirability
bias, where mothers answered with what they assumed
would be the right thing to say, rather than what they
actually practiced. However, to reduce such bias the
interviewers worked to carefully ensure friendly environ-
ment to enable open discussions and only after some
time told the women about their high viral loads that
had raised our concern. Most women then volunteered
what appeared to be truthful information regarding lack
of adherence. We also underlined the separate roles of
the first author of being a researcher rather than their
clinician at the time of this study.
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Reasons for long-term ART adherence in mothers put on
ART for life during pregnancy included lack of motivation
to continue ART after weaning the child and protecting
the child from becoming infected, stigma and poverty.
Programs that simultaneously address stigma, poverty and
women’s lack of empowerment, including interventions
aimed at helping women to problem-solve around barriers
to long-term adherence may be necessary for PMTCT and
ART to reach their full potential, especially in view of the
new WHO proposal to initiate ART for life in pregnant
women regardless of CD4 cell count.
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